Randomized, double ‐blind, placebo, and risperidone‐controlled study of lurasidone in the treatment of schizophrenia: Results of an inconclusive 6‐week trial

DiscussionThe current study was inconclusive regarding the efficacy of lurasidone in schizophrenia but further confirmed its safety and tolerability.

Source: Asia-Pacific Psychiatry - March 24, 2019 Category: Psychiatry Authors: Teruhiko Higuchi, Masaomi Iyo, Jun Soo Kwon, Yuan ‐Hwa Chou, Hsing‐Kang Chen, Jen‐Yeu Chen, Tzu‐Ting Chen, San‐Yuan Huang, Jung‐Sik Lee, Yuichi Saeki, Hisashi Tanaka, Tzong‐Shi Wang, Bo‐Jian Wu, Takao Katoh, Jun Ishigouoka Tags: ORIGINAL ARTICLE Source Type: research